Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Clot Busting Drugs Market to reach USD 53.73 billion by the end of 2030

Global Clot Busting Drugs Market Size study & Forecast, by Product (Thrombolytic Drugs, Anti-Platelet Drugs, Anticoagulants, Others) by Indication (Deep Vein Thrombosis, Atrial Fibrillation, Pulmonary Embolism, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacy, Drug Store, Online Pharmacy, Retail Pharmacy) and Regional Analysis, 2023-2030

Product Code: HLSDT-32648991
Publish Date: 20-10-2023
Page: 200

Global Clot Busting Drugs Market is valued at approximately USD 28.6 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2023-2030. Clot-busting drugs are medications used to dissolve blood clots in a medical emergency. These drugs work by activating the body’s natural clot-dissolving system, known as fibrinolysis, to break down the fibrin meshwork that forms blood clots. The most used clot-busting drug is tissue plasminogen activator (tPA), also called alteplase. tPA is a naturally occurring protein in the body that helps dissolve blood clots. The Clot Busting Drugs market is expanding because of factors such as the increasing incidence of thrombotic disorders and government initiatives and funding for the development of thrombolytic drugs.

The rising prevalence of cardiovascular diseases, deep vein thrombosis, pulmonary embolism, and ischemic stroke has led to an increased demand for clot-busting drugs. These conditions require immediate treatment to dissolve blood clots and restore blood flow, thereby driving market growth. The Global Stroke Factsheet released in 2022 reveals that the risk for developing stroke has increased by 50% over the last 17 years and as of year 2022, 1 in 4 people is estimated to have a stroke in their lifetime. Furthermore, according to World Health Organization Report 2020 around 17.9 million lives each year are being suffered from heart disorders across the globe. Thus rising prevalence of thrombotic disorders such as cardiovascular diseases and ischemic stroke is driving the market growth. In addition, advancements in clot-busting drug therapies and rising awareness and diagnosis of clotting disorders are creating a lucrative opportunity for market growth. However, the high cost of Clot Busting Drugs and advancements in interventional procedures: stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clot Busting Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, increasing disease prevalence, and a rising number of research and development activities. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the rising geriatric, increasing prevalence of diseases, an increase in the number of collaborations for product development, and active participation of government and private organizations in the market space.

Major market players included in this report are:
Bayer AG
Merck & Co
Sun Pharmaceutical Industries Ltd.
Johnson & Johnson Services Inc
Sanofi-Aventis S.A
Boehringer Ingelheim Gmbh
Dr. Reddy’s Laboratories
Genentech Inc.
Pfizer Inc.
Eli Lilly and Company

Recent Developments in the Market:
Ø In December 2021, The U.S. FDA approved XARELTO (rivaroxaban), an oral anticoagulant manufactured by Janssen Pharmaceutical. The medication has two pediatric indications, including the prevention of deep vein thrombosis (DVT) that causes pulmonary embolism.
Ø In June 2021, Boehringer Ingelheim released dabigatran etexilate, the active ingredient in Pradaxa. Pradaxa oral pellets were given FDA approval to treat venous thromboembolism, a condition in which blood clots develop in the veins, in children three months to under twelve years old.

Global Clot Busting Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Indication, Route of Administration, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Thrombolytic Drugs
Anti-Platelet Drugs
Anticoagulants
Others

By Indication:
Deep Vein Thrombosis
Atrial Fibrillation
Pulmonary Embolism
Others

By Route of Administration:
Oral
Injectable
By Distribution Channel:
Hospital Pharmacy
Drug Store
Online Pharmacy
Retail Pharmacy

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Clot Busting Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Clot Busting Drugs Market, by Product, 2020-2030 (USD Billion)
1.2.3. Clot Busting Drugs Market, by Indication, 2020-2030 (USD Billion)
1.2.4. Clot Busting Drugs Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.5. Clot Busting Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clot Busting Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clot Busting Drugs Market Dynamics
3.1. Clot Busting Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of thrombotic disorders
3.1.1.2. Government initiatives and funding for the development of thrombolytic drugs
3.1.2. Market Challenges
3.1.2.1. High Cost of Clot-Busting Drugs
3.1.2.2. Advancements in interventional procedures:
3.1.3. Market Opportunities
3.1.3.1. Advancements in clot-busting drug therapies
3.1.3.2. Rising awareness and diagnosis of clotting disorders
Chapter 4. Global Clot Busting Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Clot Busting Drugs Market, by Product
5.1. Market Snapshot
5.2. Global Clot Busting Drugs Market by Product, Performance – Potential Analysis
5.3. Global Clot Busting Drugs Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Clot Busting Drugs Market, Sub Segment Analysis
5.4.1. Thrombolytic Drugs
5.4.2. Anti-Platelet Drugs
5.4.3. Anticoagulants
5.4.4. Others
Chapter 6. Global Clot Busting Drugs Market, by Indication
6.1. Market Snapshot
6.2. Global Clot Busting Drugs Market by Indication, Performance – Potential Analysis
6.3. Global Clot Busting Drugs Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
6.4. Clot Busting Drugs Market, Sub Segment Analysis
6.4.1. Deep Vein Thrombosis
6.4.2. Atrial Fibrillation
6.4.3. Pulmonary Embolism
6.4.4. Others
Chapter 7. Global Clot Busting Drugs Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Clot Busting Drugs Market by Route of Administration, Performance – Potential Analysis
7.3. Global Clot Busting Drugs Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
7.4. Clot Busting Drugs Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Injectable
Chapter 8. Global Clot Busting Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Clot Busting Drugs Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Clot Busting Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
8.4. Clot Busting Drugs Market, Sub Segment Analysis
8.4.1. Hospital Pharmacy
8.4.2. Drug Store
8.4.3. Online Pharmacy
8.4.4. Retail Pharmacy
Chapter 9. Global Clot Busting Drugs Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Clot Busting Drugs Market, Regional Market Snapshot
9.4. North America Clot Busting Drugs Market
9.4.1. U.S. Clot Busting Drugs Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Indication breakdown estimates & forecasts, 2020-2030
9.4.1.3. Route of Administration breakdown estimates & forecasts, 2020-2030
9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Clot Busting Drugs Market
9.5. Europe Clot Busting Drugs Market Snapshot
9.5.1. U.K. Clot Busting Drugs Market
9.5.2. Germany Clot Busting Drugs Market
9.5.3. France Clot Busting Drugs Market
9.5.4. Spain Clot Busting Drugs Market
9.5.5. Italy Clot Busting Drugs Market
9.5.6. Rest of Europe Clot Busting Drugs Market
9.6. Asia-Pacific Clot Busting Drugs Market Snapshot
9.6.1. China Clot Busting Drugs Market
9.6.2. India Clot Busting Drugs Market
9.6.3. Japan Clot Busting Drugs Market
9.6.4. Australia Clot Busting Drugs Market
9.6.5. South Korea Clot Busting Drugs Market
9.6.6. Rest of Asia Pacific Clot Busting Drugs Market
9.7. Latin America Clot Busting Drugs Market Snapshot
9.7.1. Brazil Clot Busting Drugs Market
9.7.2. Mexico Clot Busting Drugs Market
9.8. Middle East & Africa Clot Busting Drugs Market
9.8.1. Saudi Arabia Clot Busting Drugs Market
9.8.2. South Africa Clot Busting Drugs Market
9.8.3. Rest of Middle East & Africa Clot Busting Drugs Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bayer AG
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Merck & Co
10.3.3. Sun Pharmaceutical Industries Ltd.
10.3.4. Johnson & Johnson Services Inc
10.3.5. Sanofi-Aventis S.A
10.3.6. Boehringer Ingelheim Gmbh
10.3.7. Dr. Reddy’s Laboratories
10.3.8. Genentech Inc.
10.3.9. Pfizer Inc.
10.3.10. Eli Lilly and Company
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now